Researchers
Discover all researchers in life sciences
Discover all researchers in life sciences
Researcher at Research Department
Ask questions about Shehryar Hameed's research, publications, and ongoing work
Developed novel benzotriazole derivatives and evaluated their potential as dual inhibitors of α-amylase and α-glucosidase enzymes, demonstrating structure-activity relationships and conducting molecular docking and kinetic studies.
Synthesized and characterized novel indazole derivatives exhibiting dual inhibitory activity against α-glucosidase and α-amylase enzymes, supported by in vitro, in silico, and kinetic studies.
Synthesized indole acrylonitrile derivatives and assessed their α-glucosidase inhibitory activity, supported by molecular docking studies to identify potential anti-hyperglycemic agents.
Synthesized and evaluated 4-amino-1,2,4-triazole derivatives for dual inhibitory activity against α-amylase and α-glucosidase enzymes, including molecular docking and kinetic studies.
Synthesized dihydropyridine derivatives and evaluated their potential as dual α-amylase and α-glucosidase inhibitors, supported by in vitro and in silico studies.
Investigated the inhibitory potential of synthetic 2-aryl quinoxaline derivatives against α-amylase, α-glucosidase, acetylcholinesterase, and butyrylcholinesterase enzymes.
Synthesized and evaluated hydrazinyl thiazole linked indenoquinoxaline hybrids for their α-amylase, α-glucosidase inhibitory, and antioxidant activities.
Dr. Shehryar Hameed is a leading researcher in the synthesis and evaluation of novel heterocyclic compounds for their therapeutic potential, particularly in diabetes and related diseases. His work focuses on developing innovative drug candidates with dual inhibitory activity against key enzymes, supported by in vitro, in silico, and kinetic studies.
Researchers with overlapping expertise and complementary work
Finding similar researchers...